Donor age-specific injury and immune responses

American Journal of Transplantation

Volumn 12, Issue 1, 2012, Pages 38-42

  Oberhuber, R ^a,b   Ge, X ^a,c   Tullius, S G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age; donor; injury and repair; transplantation

Indexed keywords

AGE; AGING; CORRELATION ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INJURY; KIDNEY TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MIDDLE AGED; TISSUE DONORS; WOUNDS AND INJURIES;

EID: 84855911567     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03798.x     Document Type: Review

References (52)

1. Port FK, Bragg-Gresham JL, Metzger RA, et al,. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281-1286. (Pubitemid 35402598)
2. Rao PS, Schaubel DE, Guidinger MK, et al,. A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index. Transplantation 2009; 88: 231-236.
3. Ojo AO, Hanson JA, Meier-Kriesche H, et al,. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589-597. (Pubitemid 32180029)
4. Merion RM, Ashby VB, Wolfe RA, et al,. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726-2733. (Pubitemid 41770102)
5. The 2009 OPTN / SRTR Annual Report: Transplant Data 1999-2008. Available from:. Accessed October 4, 2011.
6. Grams ME, Womer KL, Ugarte RM, Desai NM, Montgomery RA, Segev DL,. Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant 2010; 10: 802-809.
7. Frei U, Noeldeke J, hold-Fabrizii V, et al,. Prospective age-matching in elderly kidney transplant recipients-A 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50-57.
8. Heldal K, Hartmann A, Leivestad T, et al,. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation 2009; 87: 1045-1051.
9. Tullius SG, Tran H, Guleria I, Malek SK, Tilney NL, Milford E,. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg 2010; 252: 662-674.
10. Tullius SG, Milford E,. Kidney allocation and the aging immune response. N Engl J Med 2011; 364: 1369-1370.
11. Kasiske BL, Snyder J,. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002; 13: 1067-1072. (Pubitemid 34274105)
12. Oppenheimer F, Aljama P, Asensio PC, Bustamante BJ, Crespo Albiach JF, Guirado PL,. The impact of donor age on the results of renal transplantation. Nephrol Dial Transplant 2004; 19 (Suppl 3): iii11-iii15. (Pubitemid 38961432)
13. Reutzel-Selke A, Jurisch A, Denecke C, et al,. Donor age intensifies the early immune response after transplantation. Kidney Int 2007; 71: 629-636. (Pubitemid 46494556)
14. Abdelhafiz AH, Brown SH, Bello A, El NM,. Chronic kidney disease in older people: Physiology, pathology or both? Nephron Clin Pract 2010; 116: c19-c24.
15. Collins MG, Chang SH, Russ GR, McDonald SP,. Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005. Transplantation 2009; 87: 1201-1209.
16. Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC,. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10: 2279-2286.
17. Gill JS, Gill J, Rose C, Zalunardo N, Landsberg D,. The older living kidney donor: Part of the solution to the organ shortage. Transplantation 2006; 82: 1662-1666. (Pubitemid 46035648)
18. Iordanous Y, Seymour N, Young A, et al,. Recipient outcomes for expanded criteria living kidney donors: The disconnect between current evidence and practice. Am J Transplant 2009; 9: 1558-1573.
19. Mengel M, Chang J, Kayser D, et al,. The molecular phenotype of 6-week protocol biopsies from human renal allografts: Reflections of prior injury but not future course. Am J Transplant 2011; 11: 708-718.
20. Nanovic L, Kaplan B,. The advantage of live-donor kidney transplantation in older recipients. Nat Clin Pract Nephrol 2009; 5: 18-19.
21. Tuttle-Newhall JE, Krishnan SM, Levy MF, McBride V, Orlowski JP, Sung RS,. Organ donation and utilization in the United States: 1998-2007. Am J Transplant 2009; 9: 879-893.
22. Brook NR, White SA, Waller JR, Veitch PS, Nicholson ML,. Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 2003; 3: 614-618. (Pubitemid 36612845)
23. Summers DM, Johnson RJ, Allen J, et al,. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: A cohort study. Lancet 2010; 376: 1303-1311.
24. Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA,. Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation. Am J Transplant 2007; 7: 1797-1807. (Pubitemid 46905442)
25. Oliveira BF, Nogueira-Machado JA, Chaves MM,. The role of oxidative stress in the aging process. ScientificWorldJournal 2010; 10: 1121-1128.
26. Esposito C, Dal CA,. Functional changes in the aging kidney. J Nephrol 2010; 23 (Suppl 15): S41-S45.
27. Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N,. The thickness of the renal parenchyma decreases with age: A CT study of 360 patients. AJR Am J Roentgenol 1990; 155: 541-544.
28. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG,. The aging kidney. Kidney Int 2008; 74: 710-720.
29. Perico N, Remuzzi G, Benigni A,. Aging and the kidney. Curr Opin Nephrol Hypertens 2011; 20: 312-317.
30. Harris NR, Rumbaut RE,. Age-related responses of the microcirculation to ischemia-reperfusion and inflammation. Pathophysiology 2001; 8: 1-10. (Pubitemid 32703766)
31. Westhoff JH, Schildhorn C, Jacobi C, et al,. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010; 21: 327-336.
32. Lesnefsky EJ, Gudz TI, Migita CT, et al,. Ischemic injury to mitochondrial electron transport in the aging heart: Damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 2001; 385: 117-128. (Pubitemid 32988989)
33. Selzner M, Selzner N, Chen L, et al,. Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: Targeting liver protective strategies to patient age. Liver Transpl 2009; 15: 1594-1604.
34. Willems L, Zatta A, Holmgren K, Ashton KJ, Headrick JP,. Age-related changes in ischemic tolerance in male and female mouse hearts. J Mol Cell Cardiol 2005; 38: 245-256. (Pubitemid 40215194)
35. Tani M, Suganuma Y, Hasegawa H, et al,. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 1997; 95: 2559-2566. (Pubitemid 27233122)
36. Lloyd AC,. Limits to lifespan. Nat Cell Biol 2002; 4: E25-E27. (Pubitemid 34141467)
37. Jaskelioff M, Muller FL, Paik JH, et al,. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011; 469: 102-106.
38. Ju Z, Jiang H, Jaworski M, et al,. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med 2007; 13: 742-747. (Pubitemid 46889751)
39. Sahin E, Colla S, Liesa M, et al,. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011; 470: 359-365.
40. Grolleau-Julius A, Garg MR, Mo R, Stoolman LL, Yung RL,. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8alpha- dendritic cell function. J Gerontol A Biol Sci Med Sci 2006; 61: 1039-1047. (Pubitemid 44727211)
41. Halloran PF, Melk A, Barth C,. Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181. (Pubitemid 29034957)
42. Naesens M,. Replicative senescence in kidney aging, renal disease, and renal transplantation. Discov Med 2011; 11: 65-75.
43. Ordemann R, Hutchinson R, Friedman J, et al,. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002; 109: 1249-1256. (Pubitemid 34496603)
44. Agrawal A, Gupta S,. Impact of aging on dendritic cell functions in humans. Ageing Res Rev 2011; 10: 336-345.
45. Wong CP, Magnusson KR, Ho E,. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp Gerontol 2010; 45: 163-169.
46. Jurewicz M, Ueno T, Azzi J, et al,. Donor antioxidant strategy prolongs cardiac allograft survival by attenuating tissue dendritic cell immunogenicity. Am J Transplant 2011; 11: 348-355.
47. Song K, Chen Y, Goke R, et al,. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191: 1095-1104.
48. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM,. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898. (Pubitemid 28096086)
49. Agrawal A, Agrawal S, Tay J, Gupta S,. Biology of dendritic cells in aging. J Clin Immunol 2008; 28: 14-20.
50. Pratschke J, Merk V, Reutzel-Selke A, et al,. Potent early immune response after kidney transplantation in patients of the European senior transplant program. Transplantation 2009; 87: 992-1000.
51. Reutzel-Selke A, Filatenkov A, Jurisch A, et al,. Grafts from elderly donors elicit a stronger immune response in the early period posttransplantation: A study in a rat model. Transplant Proc 2005; 37: 382-383. (Pubitemid 40459794)
52. Sung RS, Christensen LL, Leichtman AB, et al,. Determinants of discard of expanded criteria donor kidneys: Impact of biopsy and machine perfusion. Am J Transplant 2008; 8: 783-792. (Pubitemid 351347765)